1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium
Publication
, Conference
Ravi, P; Xie, W; Buyse, ME; Halabi, S; Kantoff, PW; Sartor, O; Attard, G; Clarke, NW; D'Amico, A; Dignam, J; James, ND; Fizazi, K; Sandler, H ...
Published in: Annals of Oncology
October 2023
Duke Scholars
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
October 2023
Volume
34
Start / End Page
S954 / S954
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ravi, P., Xie, W., Buyse, M. E., Halabi, S., Kantoff, P. W., Sartor, O., … Sweeney, C. (2023). 1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium. In Annals of Oncology (Vol. 34, pp. S954–S954). Elsevier BV. https://doi.org/10.1016/j.annonc.2023.09.2720
Ravi, P., W. Xie, M. E. Buyse, S. Halabi, P. W. Kantoff, O. Sartor, G. Attard, et al. “1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium.” In Annals of Oncology, 34:S954–S954. Elsevier BV, 2023. https://doi.org/10.1016/j.annonc.2023.09.2720.
Ravi P, Xie W, Buyse ME, Halabi S, Kantoff PW, Sartor O, et al. 1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium. In: Annals of Oncology. Elsevier BV; 2023. p. S954–S954.
Ravi, P., et al. “1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium.” Annals of Oncology, vol. 34, Elsevier BV, 2023, pp. S954–S954. Crossref, doi:10.1016/j.annonc.2023.09.2720.
Ravi P, Xie W, Buyse ME, Halabi S, Kantoff PW, Sartor O, Attard G, Clarke NW, D’Amico A, Dignam J, James ND, Fizazi K, Gillessen S, Parulekar WR, Sandler H, Spratt D, Sydes MR, Tombal B, Williams S, Sweeney C. 1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium. Annals of Oncology. Elsevier BV; 2023. p. S954–S954.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
October 2023
Volume
34
Start / End Page
S954 / S954
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis